Gut barrier failure biomarkers are associated with poor disease outcome in patients with primary sclerosing cholangitisTamás Tornai, Mária Papp, Gábor Veres et al.|World Journal of Gastroenterology|2017Cited by 48
Loss of tolerance to gut immunity protein, glycoprotein 2 (GP2) is associated with progressive disease course in primary sclerosing cholangitisTamás Tornai, Mária Papp, Dávid Tornai et al.|Scientific Reports|2018Cited by 31
Longitudinal Comparison of Currently Used Risk Scores for Prognostication of Primary Sclerosing Cholangitis (PSC) in a Hungarian Bicenter PSC CohortPeter Laszlo Ven, Mária Papp, Dávid Tornai et al.|Diagnostics|2025Cited by 2
THU-367 Prognosis of primary sclerosing cholangitis (PSC) in Hungary is independent of coexisting inflammatory bowel disease (IBD) and prognostic ability of the currently used PSC risk scores are limitedDávid Tornai, Mária Papp, Peter Laszlo Ven et al.|Journal of Hepatology|2025Cited by 0